PPT-Module 3: Chronic Lymphocytic Leukemia

Author : CottonTails | Published Date : 2022-07-28

Josie Montegaard MSN AGPCNPBC Matthew S Davids MD MMSc Disclosures for Ms Montegaard Advisory Committee Janssen Biotech Inc Pharmacyclics LLC an AbbVie

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Module 3: Chronic Lymphocytic Leukemia" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Module 3: Chronic Lymphocytic Leukemia: Transcript


Josie Montegaard MSN AGPCNPBC Matthew S Davids MD MMSc Disclosures for Ms Montegaard Advisory Committee Janssen Biotech Inc Pharmacyclics LLC an AbbVie Company Consulting Agreements . Rita All. Carrie Warner. Definition. Leukemia is a group of malignant diseases that result in changes to circulating lymphocytes characterized by diffuse, abnormal growth of . leukocytic. precursors in the marrow.. Spring 2010. Clinical history. A 62 year old man presents to his primary care physician with lymphadenopathy. . A CBC demonstrates the following: . WBC 20.73 thousand cell/microliter . 12% neutrophils. case report hronic lymphocytic leukaemia (CLL) is a low-lymphocytes in the peripheral blood, bone marrow, CLL requires the presence of more than 5 x 10blood (3). Flow cytometry will demonstrate clonal Mary E. MacBlane MS, PNP-BC. Goals. Incidence. Etiology. Diagnosis. Types/Classification. Treatment. Primary Care Pearls. Incidence. 30% of all cancers in childhood. Peak incidence 2-5 years of age. males > females. By: . Ashlynn. Hill. Patrice Thompson. 3 year who is battling leukemia.. The doctors suggest a bone marrow transplants for a long term survival.. Neither parents have matching bone marrows.. The parents consult with a genetic consoler and a reproductive specialist to discuss the possibilities of having another child to have matching bone marrow.. Overview. Overview (cont). Ibrutinib. -R. elated Cardiovascular A. E. s. Atrial Fibrillation. Ibrutinib-Related AF Data From 2016 ASH Conference. Wiczer et al Data. Risk Stratification. . Mechanisms of Ibrutinib-Related Cardiotoxicity. a closer look . SEER HEMATOPOIETIC DATABASE. Understanding the disease. AMBIGUOUS TERMS. Choosing . the right . Histology & TOPO CODE . Navigation of the Hematopoietic and Lymphoid Neoplasm Database . 45 KEYWORDS Letterer-Siwe disease, chronic myelomonocytic leukemiaUMMARY Introduction 46 Case reportsLetterer-Siwe disease and chronic myelomyonocytic leukemiaActa Dermatoven APA Vol 19, 2010, No 1 re Do you want an interactive workbook that will support you in following THE raw vegan healing protocol that was intended for our species? Then this book is for you! This is a strategically composed workbook which contains invaluable information, a series of tips, pointers, and protocols which are geared towards healing you naturally. Through years of experience, we learnt a vast amount about human healing and we wanted to deliver this information to you in a practical and applicable way. With the help of this workbook companion, you will now be able to achieve your individual health goals easily. It is now your turn to experience instant positive changes in your life and health. Good luck on your journey. Multiple Myeloma . Chronic Leukemia. Chronic leukemia consists of a number of disorders, including; . chronic myeloid leukemia. (CML) . (also called chronic . myelogenous. leukemia. BSW00073 / OK 11 - ONC - 152 1 July , 2011 Fact Sheet Leukemia is a cancer that begins in the bone marrow ( the soft inner part of some bones), but in most cases, moves into the blood. It can t hen s CONSULTANT HAEMATOLOGIST . HEAD OF HAEMATOLOGY DIVISION. DEPARTMENT OF PATHOLOGY. Heterogeneous group of hematopoietic . neoplasms. Uncontrolled . proliferation and . decreased apoptotic . activity with variable degrees of differentiation . Dr Mona Yuklea. Hematology Department, Meir Hospital, 2019. CLL - incidence. The most common leukemia among adults in Western Countries. 4-6 cases /100000 person/year. At diagnosis. More than 70% of patients – older than 65 y. Jayllex Mills,. PharmD Candidate. AML Background. Hematologic malignancy affecting the blood and bone marrow. Result of proliferation of abnormal myeloid stem cell derivatives and interference of normal blood cell production.

Download Document

Here is the link to download the presentation.
"Module 3: Chronic Lymphocytic Leukemia"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents